Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SKF 86466 is an antagonist of α2-adrenergic receptors (α2-ARs; Kis = 9.4, 16, and 20 nM for α2A, α2B, and α2C receptors, respectively).1 It is selective for α2-ARs over α1-ARs (Kis = 449, 485, and 126 nM for α1A, α1B, and α1D receptors, respectively). SKF 86466 inhibits contractions in rabbit aorta and canine saphenous vein induced by norepinephrine or B-HT 920 (Item No. 14177), respectively (KBs = 600 and 42 nM, respectively). It decreases diastolic blood pressure in DOCA-salt hypertensive, spontaneously hypertensive, and two kidney-one clip (2K-1C) renal hypertensive rats when administered at a dose of 2 mg/kg, i.v.2 SKF 86466 (1 mg/kg) reduces muscle rigidity induced by reserpine (Item No. 19474) in a mouse model of Parkinson’s disease.3
WARNING This product is not for human or veterinary use.
1. α-
2. Characterization of the antihypertensive activity of SK&F 86466, a selective alpha-
3. Imidazoline I1 receptor-